ESCs carrying the AML-associated mutation SMC1A-R586W exhibit diminished P-E interaction, which leads to dysregulation of the expression of pluripotent genes (e.g., Oct4 and Nanog) [79]. This evidence concerns the gene NANOG and acute myeloid leukemia.